RONALD DINGWELL: Open Payments
NPI 1619080249 · WEST HEMPSTEAD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$534 in 20 payments from 6 companies in 2025. Trend: 2023 $987 · 2024 $802 · 2025 $534
Food & beverage: $534
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 9 | $185 |
| E.R. Squibb & Sons, L.L.C. | 1 | $124 |
| Teva Pharmaceuticals USA, Inc. | 5 | $103 |
| Otsuka America Pharmaceutical, Inc. | 2 | $54 |
| Lundbeck LLC | 2 | $46 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
Products named: INGREZZA, COBENFY, UZEDY, REXULTI, ABILIFY MAINTENA, SPRAVATO, AUSTEDO XR.
Industry payments across NY — which companies pay providers there.
